Home › Gilead combo HIV pill matches Truvada efficacy but safer in trial
 

Keywords :   


Gilead combo HIV pill matches Truvada efficacy but safer in trial

2015-09-02 18:18:32| Biotech - Topix.net

REUTERS: Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function. The company has already sought U.S. and European marketing approval for the new combo pill nicknamed F/TAF, which is meant to be a safer replacement for Truvada, a cornerstone of HIV treatment that has been associated with slight declines in bone mineral density and kidney function.

Tags: trial matches combo hiv

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Portugal\'s Etifam adds Screen Truepress Label 350UV SAI-E
15.05Tom Hardy Is Jo Malone Londons New Ambassador for Cypress & Grapevine Cologne Intense
15.05Mooncat Introduces New Hue, Holds Bi-Annual Sale
15.05Eastern North Pacific Tropical Weather Outlook
15.05European Wax Center\'s EWC Treat Brightening Ingrown Hair Wipes Awarded
15.05EchoStar pay TV subscribers down 348,000 in 1Q 2024
15.05Atlantic Tropical Weather Outlook
15.05PBE Makes Investment in Plus-Size Adult Incontinence Products
More »